125 related articles for article (PubMed ID: 18507721)
1. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children.
Balagopal P; George D; Sweeten S; Mann KJ; Yarandi H; Mauras N; Vaughan DE
J Thromb Haemost; 2008 Aug; 6(8):1296-303. PubMed ID: 18507721
[TBL] [Abstract][Full Text] [Related]
2. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related increased γ' fibrinogen concentration in children and its reduction by a physical activity-based lifestyle intervention: a randomized controlled study.
Lovely R; Hossain J; Ramsey JP; Komakula V; George D; Farrell DH; Balagopal PB
J Pediatr; 2013 Aug; 163(2):333-8. PubMed ID: 23415619
[TBL] [Abstract][Full Text] [Related]
4. Weight loss induced by 6-month lifestyle intervention improves early endothelial activation and fibrinolysis in obese adolescents.
Huang F; del-Río-Navarro BE; de Castro GT; Alcántara ST; Sienra Monge JJ; Ontiveros JA; Olivos EN; Barron MF; Lopéz AR; Villafaña S; Hong E
Child Care Health Dev; 2011 May; 37(3):377-84. PubMed ID: 21198775
[TBL] [Abstract][Full Text] [Related]
5. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
Belalcazar LM; Ballantyne CM; Lang W; Haffner SM; Rushing J; Schwenke DC; Pi-Sunyer FX; Tracy RP;
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1689-95. PubMed ID: 21512162
[TBL] [Abstract][Full Text] [Related]
6. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
8. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A; Galar M
Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity in laparoscopic cholecystectomy.
Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
[TBL] [Abstract][Full Text] [Related]
11. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents.
Balagopal P; Sweeten S; Mauras N
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E899-904. PubMed ID: 11882510
[TBL] [Abstract][Full Text] [Related]
12. Prospective double-arm study of fibrinolysis in surgical patients.
Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
[TBL] [Abstract][Full Text] [Related]
13. Negative correlation between D-dimer and plasminogen activator inhibitor-1 levels is absent in obese women.
Ceo PT; Petruceli E; Bosco AA; Andrade-Fernandes CM; Russi CV; Carvalho Md; Sandrim VC
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):402-5. PubMed ID: 22527291
[TBL] [Abstract][Full Text] [Related]
14. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Ray MJ; Marsh NA; Hawson GA
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
[TBL] [Abstract][Full Text] [Related]
15. Evidence that fibrinolytic changes in paediatric obesity translate into a hypofibrinolytic state: relative contribution of TAFI and PAI-1.
Semeraro F; Giordano P; Faienza MF; Cavallo L; Semeraro N; Colucci M
Thromb Haemost; 2012 Aug; 108(2):311-7. PubMed ID: 22740053
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
17. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients.
Burleson A; Guler N; Banos A; Syed D; Wanderling C; Hoppensteadt D; Rees H; Fareed J; Hopkinson W
Clin Appl Thromb Hemost; 2016 Apr; 22(3):274-9. PubMed ID: 26460335
[TBL] [Abstract][Full Text] [Related]
19. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
Wieczór R; Wieczór AM; Kulwas A; Rość D
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
